News Roundup
- Vizient Doubles its High-Value Provider Network for Self-Insured Employers: Vizient, Inc. announces the expansion of its provider-led, quality-driven surgical care network collaborating to offer bundled pricing for select surgeries to large, self-insured employers. Vizient Newsroom
- NEW PRODUCT APPLICATIONS: Ranibizumab Biosimilar Offers Lower-price Treatment Option: With the patent for Lucentis expiring in 2020, Coherus BioSciences of Redwood City, California, saw an opportunity to create a biosimilar product that would be interchangeable with Lucentis. Retinal Physician
- Vizient Hosts Congressional Briefing on Pressures Facing Hospitals: Hospital leaders highlighted their focus on enhancing primary care access, providing clinical education, initiatives to support maternal health and reduce health disparities, and supporting patient access to care through hospital-at-home programs and rural healthcare facility investments. Vizient Newsroom
- Vizient Offers Comments to CMS on Prior Authorization Proposed Rules: Vizient submitted comments on the Centers for Medicare & Medicaid Services' proposed rule to improve prior authorization processes for various plans and payers. Vizient Newsroom
- Vizient Shares Feedback on Reauthorization of the Pandemics and All-Hazards Preparedness Act: Vizient weighed in on various policies that will need to be reauthorized and offered suggestions to improve the nation's public health and emergency preparedness and response capabilities. Vizient Newsroom
Blogs You May Have Missed